OpenAlex
PricingAboutJobs
Log inGet started
Work

Effect of Rosiglitazone Treatment on Soluble CD40L in Patients With Type 2 Diabetes and Coronary Artery Disease

HTML

Year: 2003
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Circulation
DOI: 10.1161/01.cir.0000069272.06194.91
Authors: Nikolaus Marx, Armin Imhof, Johannes Froehlich, Laila Siam, Jochen Ittner, Gerhard Wierse, Arnold Schmidt, Winfried Maerz, Vinzenz Hombach, Wolfgang Koenig
Institutions: University of Freiburg, Universität Ulm
Language: English

Topic: Peroxisome Proliferator-Activated Receptors
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: rosiglitazone, soluble CD40 ligand, type 2 diabetes, coronary artery disease, thiazolidinediones, PPARγ, inflammation, atherogenesis, anti-inflammatory activity, cardiovascular risk
SDG: Good health and well-being

Open Access status: closed

Funders: Deutsche Forschungsgemeinschaft, Universität Ulm
Award: G59302984
OpenAlex ID: W2008674682
FWCI: 7.444
Cites: 13
Cited by: 230
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms